모든 카드

카드 내용은 中文·English·日本語로 제공되며 이 언어에서는 영어판을 표시합니다.

BONES, JOINTS & MUSCLESGlucosamine: what the bigtrials found1GAIT (NEJM 2006): pain response placebo 60%,glucosamine 64%, chondroitin 65%, both 67% — nonesignificant2BMJ 2010 (3,803 people): pain improved 0.3–0.5 cm ona 10-cm scale, below the 0.9 cm that mattersclinically3Joint-space change on X-ray same as placebo — no“cartilage repair”4Industry-funded trials showed 0.5 cm more effect thanindependent ones5ACR 2019, OARSI 2019 and NICE 2022 all recommendagainst6What works: exercise therapy and weight loss (each kglost cuts knee load by about 4 kg)Kidney patients: some products carry potassium or sodium; possibleinteraction with warfarin. Fairly safe — just don’t skip theexercise.BBeyond CKDbeyondckd.com/ko/cards/glucosamine-what-trials-foundSources: Clegg DO et al. GAIT · Wandel S et al. Glucosamine/chondroitin network…Compiled from public clinical guidelines · General education, not individual medical advice
LINE Facebook

Bones, joints & muscles

Glucosamine: what the big trials found

Ten years on glucosamine? Here’s the NIH 1,583-person trial and the BMJ meta-analysis.

  1. 1GAIT (NEJM 2006): pain response placebo 60%, glucosamine 64%, chondroitin 65%, both 67% — none significant
  2. 2BMJ 2010 (3,803 people): pain improved 0.3–0.5 cm on a 10-cm scale, below the 0.9 cm that matters clinically
  3. 3Joint-space change on X-ray same as placebo — no “cartilage repair”
  4. 4Industry-funded trials showed 0.5 cm more effect than independent ones
  5. 5ACR 2019, OARSI 2019 and NICE 2022 all recommend against
  6. 6What works: exercise therapy and weight loss (each kg lost cuts knee load by about 4 kg)

Kidney patients: some products carry potassium or sodium; possible interaction with warfarin. Fairly safe — just don’t skip the exercise.

게시글 문구(바로 붙여넣기)

Ten years on glucosamine? Here’s the NIH 1,583-person trial and the BMJ meta-analysis.

1. GAIT (NEJM 2006): pain response placebo 60%, glucosamine 64%, chondroitin 65%, both 67% — none significant
2. BMJ 2010 (3,803 people): pain improved 0.3–0.5 cm on a 10-cm scale, below the 0.9 cm that matters clinically
3. Joint-space change on X-ray same as placebo — no “cartilage repair”
4. Industry-funded trials showed 0.5 cm more effect than independent ones
5. ACR 2019, OARSI 2019 and NICE 2022 all recommend against
6. What works: exercise therapy and weight loss (each kg lost cuts knee load by about 4 kg)

Kidney patients: some products carry potassium or sodium; possible interaction with warfarin. Fairly safe — just don’t skip the exercise.

출처(카드의 각 항목과 대응): Clegg DO et al. GAIT — N Engl J Med 2006; Wandel S et al. Glucosamine/chondroitin network meta-analysis — BMJ 2010
확인일: 2026-10-17

카드와 대본은 공개 임상 가이드라인에 근거한 일반 건강 교육 정보이며 개인 의료 조언이 아니고 의사·약사·영양사의 평가를 대신하지 않습니다. 공유 시 출처와 이 안내를 유지해 주세요. 최신판은 이 페이지가 기준입니다.
https://beyondckd.com/ko/cards/glucosamine-what-trials-found
60초 숏폼 영상 대본

장면과 내레이션. 세로 9:16, 자막은 하단 1/3에. 각 내레이션은 왼쪽 출처와 대응.

초화면내레이션
0–5Glucosamine jarAll these years — did it work?
5–25GAIT five barsThe NIH-funded GAIT trial: placebo 60%, glucosamine 64%, chondroitin 65%, both 67% — none significant.
25–45BMJ 0.9 cm thresholdBMJ pooled ten large trials: pain improved only 0.3 to 0.5 cm; joint space changed the same as placebo.
45–60Exercise + scaleGuidelines recommend against it. What works is exercise and weight loss — every kilo lost takes four off your knees.

출처(카드의 각 항목과 대응)

확인일: 2026-10-17